Latest Insider Transactions at Corcept Therapeutics Inc (CORT)
This section provides a real-time view of insider transactions for Corcept Therapeutics Inc (CORT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CORCEPT THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CORCEPT THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 07
2021
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
25,000
-45.43%
|
$550,000
$22.19 P/Share
|
Jul 07
2021
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+31.24%
|
$75,000
$3.29 P/Share
|
Jun 11
2021
|
G Leonard Baker Jr Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+2.93%
|
$2,100,000
$21.53 P/Share
|
Jun 11
2021
|
G Leonard Baker Jr Director |
BUY
Open market or private purchase
|
Direct |
50,000
+4.56%
|
$1,050,000
$21.53 P/Share
|
Jun 02
2021
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
7,500
-100.0%
|
$157,500
$21.48 P/Share
|
Jun 02
2021
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$45,000
$6.55 P/Share
|
May 18
2021
|
G Leonard Baker Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+2.69%
|
$450,000
$3.7 P/Share
|
May 11
2021
|
David L Mahoney |
SELL
Payment of exercise price or tax liability
|
Direct |
6,484
-5.45%
|
$129,680
$20.45 P/Share
|
May 11
2021
|
David L Mahoney |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+20.14%
|
$120,000
$4.42 P/Share
|
Apr 23
2021
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-11.68%
|
$240,000
$24.02 P/Share
|
Apr 14
2021
|
James N Wilson |
BUY
Other acquisition or disposition
|
Indirect |
109,483
+8.52%
|
-
|
Apr 14
2021
|
James N Wilson |
SELL
Other acquisition or disposition
|
Direct |
109,483
-100.0%
|
-
|
Apr 14
2021
|
James N Wilson |
SELL
Payment of exercise price or tax liability
|
Direct |
90,517
-45.26%
|
$1,991,374
$22.95 P/Share
|
Apr 14
2021
|
James N Wilson |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+50.0%
|
$800,000
$4.42 P/Share
|
Apr 05
2021
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
7,500
-100.0%
|
$180,000
$24.14 P/Share
|
Apr 05
2021
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$45,000
$6.55 P/Share
|
Apr 01
2021
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$575,000
$23.88 P/Share
|
Apr 01
2021
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$275,000
$11.35 P/Share
|
Mar 01
2021
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$625,000
$25.21 P/Share
|
Mar 01
2021
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$200,000
$8.27 P/Share
|
Feb 16
2021
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
8,989
-23.04%
|
$251,692
$28.25 P/Share
|
Feb 16
2021
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
8,989
+18.73%
|
$26,967
$3.29 P/Share
|
Feb 12
2021
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
112,100
-56.69%
|
$3,138,800
$28.22 P/Share
|
Feb 11
2021
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,400
-1.69%
|
$98,600
$29.78 P/Share
|
Feb 11
2021
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
3,400
-10.17%
|
$98,600
$29.78 P/Share
|
Feb 11
2021
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
3,400
+9.23%
|
$10,200
$3.29 P/Share
|
Feb 03
2021
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$725,000
$29.18 P/Share
|
Feb 03
2021
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$200,000
$8.27 P/Share
|
Jan 22
2021
|
Joseph K Belanoff Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
481,088
-14.58%
|
$13,470,464
$28.06 P/Share
|
Jan 22
2021
|
Joseph K Belanoff Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
800,000
+19.52%
|
$3,200,000
$4.42 P/Share
|
Jan 22
2021
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
258,739
-56.26%
|
$7,244,692
$28.06 P/Share
|
Jan 22
2021
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
451,852
+49.56%
|
$903,704
$2.7 P/Share
|
Jan 21
2021
|
James N Wilson |
SELL
Bona fide gift
|
Indirect |
12,000
-1.02%
|
-
|
Jan 19
2021
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$140,000
$28.74 P/Share
|
Jan 19
2021
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.55 P/Share
|
Jan 04
2021
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$650,000
$26.13 P/Share
|
Jan 04
2021
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$200,000
$8.27 P/Share
|
Dec 30
2020
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$650,000
$26.07 P/Share
|
Dec 30
2020
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+47.73%
|
$150,000
$6.08 P/Share
|
Dec 01
2020
|
G Leonard Baker Jr Director |
BUY
Open market or private purchase
|
Indirect |
68
+0.0%
|
$1,496
$22.64 P/Share
|
Nov 30
2020
|
G Leonard Baker Jr Director |
BUY
Open market or private purchase
|
Indirect |
1,109
+0.03%
|
$24,398
$22.8 P/Share
|
Nov 25
2020
|
G Leonard Baker Jr Director |
BUY
Open market or private purchase
|
Indirect |
361
+0.01%
|
$7,942
$22.81 P/Share
|
Nov 24
2020
|
Hazel Hunt Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
31,225
-62.2%
|
$686,950
$22.88 P/Share
|
Nov 24
2020
|
Hazel Hunt Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.9%
|
$150,000
$3.96 P/Share
|
Nov 24
2020
|
G Leonard Baker Jr Director |
BUY
Open market or private purchase
|
Indirect |
1,429
+0.04%
|
$31,438
$22.93 P/Share
|
Nov 23
2020
|
G Leonard Baker Jr Director |
BUY
Open market or private purchase
|
Indirect |
1,551
+0.05%
|
$34,122
$22.93 P/Share
|
Nov 18
2020
|
G Leonard Baker Jr Director |
BUY
Open market or private purchase
|
Indirect |
2,372
+0.07%
|
$40,324
$17.91 P/Share
|
Nov 17
2020
|
G Leonard Baker Jr Director |
BUY
Open market or private purchase
|
Indirect |
7,883
+0.25%
|
$134,011
$17.82 P/Share
|
Nov 16
2020
|
Gary Charles Robb Chief Business Officer |
BUY
Bona fide gift
|
Indirect |
2,487
+15.37%
|
-
|
Nov 13
2020
|
G Leonard Baker Jr Director |
BUY
Open market or private purchase
|
Indirect |
200
+0.01%
|
$3,400
$17.94 P/Share
|